Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 5 Dermatologic 1

Conditions

Interventions

pembrolizumab 100 Nivolumab 69 Cyclophosphamide 67 Ipilimumab 66 fludarabine 34 aldesleukin 29 fludarabine phosphate 28 Vemurafenib 28 Interleukin-2 26 trametinib 20 Biopsy 20 dabrafenib 17 Radiotherapy 16 Temozolomide 15 Cisplatin 15 Magnetic Resonance Spectroscopy 14 Gemcitabine 14 Filgrastim 14 atezolizumab 13 Specimen Handling 13 Carboplatin 13 CTLA-4 Antigen 13 spartalizumab 12 romidepsin 12 Paclitaxel 12 Bortezomib 11 poly ICLC 10 cobimetinib 10 Peripheral Blood Stem Cell Transplantation 10 Oxaliplatin 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Diphtheria-Tetanus Vaccine × Dermatologic × Clear all

NCT05077137 2025-08-27

TdVax

Duke University

Phase 1 Recruiting

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡